Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.
2.

Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells.

Juhl H, Petrella EC, Cheung NK, Bredehorst R, Vogel CW.

Immunobiology. 1997 Nov;197(5):444-59.

PMID:
9413745
3.

A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach.

Juhl H, Sievers M, Baltzer K, Helmig F, Wolf H, Brenner W, Kalthoff H.

Cancer Res. 1995 Dec 1;55(23 Suppl):5749s-5755s.

4.

Cobra venom factor immunoconjugates: effects of carbohydrate-directed versus amino group-directed conjugation.

Zara J, Pomato N, McCabe RP, Bredehorst R, Vogel CW.

Bioconjug Chem. 1995 Jul-Aug;6(4):367-72.

PMID:
7578355
6.

Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro.

Cheung NK, Walter EI, Smith-Mensah WH, Ratnoff WD, Tykocinski ML, Medof ME.

J Clin Invest. 1988 Apr;81(4):1122-8.

7.
8.

Antibody conjugates with cobra venom factor. Synthesis and biochemical characterization.

Petrella EC, Wilkie SD, Smith CA, Morgan AC Jr, Vogel CW.

J Immunol Methods. 1987 Nov 23;104(1-2):159-72.

PMID:
3500233
9.
10.

Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses.

Ugur O, Kostakoglu L, Hui ET, Fisher DR, Garmestani K, Gansow OA, Cheung NK, Larson SM.

Nucl Med Biol. 1996 Jan;23(1):1-8.

PMID:
9004907
15.

Structure and function of recombinant cobra venom factor.

Kock MA, Hew BE, Bammert H, Fritzinger DC, Vogel CW.

J Biol Chem. 2004 Jul 16;279(29):30836-43. Epub 2004 May 5.

16.
17.

Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.

Kölln J, Matzas M, Jänner N, Mix T, Klensang K, Bredehorst R, Spillner E.

Mol Immunol. 2004 May;41(1):19-28.

PMID:
15140572
18.

A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.

Brezski RJ, Kinder M, Grugan KD, Soring KL, Carton J, Greenplate AR, Petley T, Capaldi D, Brosnan K, Emmell E, Watson S, Jordan RE.

MAbs. 2014;6(5):1265-73. doi: 10.4161/mabs.29825. Epub 2014 Oct 30.

19.

Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxin.

Siegall CB, Gawlak SL, Chin JJ, Zoeckler ME, Kadow KF, Brown JP, Braslawsky GR.

Bioconjug Chem. 1992 Jul-Aug;3(4):302-7.

PMID:
1390985
20.

Generation and characterization of transgenic mice expressing cobra venom factor.

Andrä J, Halter R, Kock MA, Niemann H, Vogel CW, Paul D.

Mol Immunol. 2002 Oct;39(5-6):357-65.

PMID:
12220893

Supplemental Content

Support Center